Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0314719 (dry eye)
 2,625 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Sodium hyaluronate solution is known to relieve various dry eye symptoms by suppressing the breakup of the preocular tear film. Using tear film stability as a parameter, we examined in 12 volunteers the time and concentration-dependent effects of sodium hyaluronate on their short precorneal tear film breakup time (BUT, 10 sec. or less) at a low tear volume (15 mm or less by using the phenol red thread test). Each subject underwent four separate study periods, receiving one of the following four ophthalmic solutions during each period: 0.05, 0.1, 0.3% w/v sodium hyaluronate (molecular weight, about 1,000,000) or the vehicle alone. BUT was measured non-invasively using a non-contact specular microscope before and 5, 15, 30, 60, 120, and 180 minutes after drug application. While BUT was not significantly prolonged after instilling either the vehicle or 0.05% solution, it was significantly increased at all times after applying either 0.1% or 0.3% solution, as compared to preinstillation. These results indicate that sodium hyaluronate solutions at concentrations of at least 0.1% can be effective in alleviating symptoms of dry eye.
 ...
PMID:[Evaluation of the effect of the sodium hyaluronate ophthalmic solution on tear film stability--non-contact specular microscopic evaluation]. 836 80

Sodium hyaluronate eyedrops can relieve various dry eye symptoms by prolonging the stability of the precorneal tear film. To determine the most effective concentration of sodium hyaluronate, we studied the concentration-dependent effects of sodium hyaluronate eyedrops on the precorneal tear film breakup time (BUT) in 12 volunteers. These subjects had a BUT of 10 seconds or less and a low tear volume determined with the phenol red thread test. They received four different concentrations of sodium hyaluronate eyedrops (0, 0.05, 0.1 and 0.3%). BUT was measured noninvasively using a non-contact specular microscope before the sodium hyaluronate eyedrop instillation and again after 5, 15, 30, 60, 120 and 180 minutes. The tear film stability period was prolonged significantly with 0.1% and 0.3% eyedrops at all measurement times (P < 0.05), while the eyes treated with 0% and 0.05% eyedrops showed no significant prolongation of tear film stability at any measurement times. The findings of this study confirm that sodium hyaluronate at a concentration of at least 0.1% is required to delay the breakup of the precorneal tear film.
 ...
PMID:Sodium hyaluronate eyedrops enhance tear film stability. 873 1